John Gallagher Sells 430 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) COO John Gallagher sold 430 shares of Trupanion stock in a transaction on Wednesday, January 28th. The shares were sold at an average price of $31.67, for a total value of $13,618.10. Following the completion of the transaction, the chief operating officer directly owned 31,861 shares of the company’s stock, valued at $1,009,037.87. This represents a 1.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Trupanion Price Performance

Shares of TRUP stock opened at $31.99 on Friday. The company has a market cap of $1.38 billion, a P/E ratio of 88.86 and a beta of 1.58. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.31. The business has a fifty day simple moving average of $35.56 and a 200 day simple moving average of $41.35. Trupanion, Inc. has a twelve month low of $30.85 and a twelve month high of $57.88.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Thursday, November 6th. The financial services provider reported $0.13 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.76). Trupanion had a net margin of 1.10% and a return on equity of 4.48%. The firm had revenue of $366.92 million during the quarter, compared to the consensus estimate of $361.58 million. During the same quarter in the prior year, the business posted $0.03 earnings per share. Trupanion’s revenue for the quarter was up 12.0% compared to the same quarter last year. On average, sell-side analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on TRUP shares. Piper Sandler cut their price target on Trupanion from $67.00 to $60.00 and set an “overweight” rating on the stock in a report on Friday, December 19th. Cantor Fitzgerald decreased their price target on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a research note on Wednesday, January 14th. Stifel Nicolaus dropped their price objective on shares of Trupanion from $42.00 to $38.00 and set a “hold” rating on the stock in a report on Thursday. Zacks Research raised Trupanion from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 6th. Finally, Wall Street Zen lowered Trupanion from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $50.00.

Institutional Investors Weigh In On Trupanion

Several large investors have recently added to or reduced their stakes in TRUP. Federated Hermes Inc. purchased a new position in Trupanion in the 3rd quarter valued at approximately $33,000. Pilgrim Partners Asia Pte Ltd bought a new position in shares of Trupanion in the third quarter worth $39,000. Nisa Investment Advisors LLC grew its position in shares of Trupanion by 44.1% in the second quarter. Nisa Investment Advisors LLC now owns 980 shares of the financial services provider’s stock valued at $54,000 after purchasing an additional 300 shares in the last quarter. Kelleher Financial Advisors bought a new stake in shares of Trupanion during the 3rd quarter valued at $74,000. Finally, PNC Financial Services Group Inc. raised its stake in shares of Trupanion by 21.7% during the 3rd quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock valued at $116,000 after purchasing an additional 478 shares during the period.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.